Twist Bioscience: Fiscal 4Q Earnings Snapshot

SAN FRANCISCO (AP) _ Twist Bioscience Corp. (TWST) on Wednesday reported a loss of $31.2 million in its fiscal fourth quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 96 cents.

The maker of synthetic DNA for the biotechnology industry posted revenue of $15.7 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $14.1 million.

For the year, the company reported that its loss widened to $107.7 million, or $3.92 per share. Revenue was reported as $54.4 million.

For the current quarter ending in January, Twist Bioscience said it expects revenue in the range of $15 million to $16.5 million.

The company expects full-year revenue in the range of $80 million to $84 million.

Twist Bioscience shares have climbed 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $25.97, an increase of 13% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST